Coordination of diabetic retinopathy screening in the Kimberley region of Western Australia.

Aust J Rural Health

Centre for Ophthalmology & Visual Sciences (incorporating the Lions Eye Institute), The University of Western Australia, Perth, Western Australia, Australia.

Published: April 2017

Objective: To determine the coverage provided by the Kimberley Diabetic Retinopathy Screening Program and evaluate the impact of the Kimberley diabetic eye health coordinator (KDEHC) position using an evidence-based approach.

Design: Retrospective audit.

Setting: Primary care services in the Kimberley region of Western Australia.

Participants: Individuals with diabetes mellitus who underwent screening for diabetic retinopathy (DR) from 1 March 2010 to 28 February 2014.

Interventions: A KDEHC was engaged from February 2012 to provide coordination and support for the DR screening program.

Main Outcome Measure(s): Coverage provided by the program for Indigenous Australians with diabetes, as measured against annual projected needs for diabetic eye examinations.

Results: Data were collected for 1247 screening episodes for 947 Indigenous Australian patients. Coverage provided by the program increased from 9.44% in 2010-2011 to 29.8% in 2013-2014 (P < 0.05). The number of sites engaged in screening increased from four in 2010-2011 to 17 in 2013-2014. After the engagement of the KDEHC, significant increases in visual acuity recording and coverage were observed, as well as a non-significant increase in photo quality.

Conclusions: Engagement of the KDEHC was associated with significant increases in program coverage. Despite the observed increase, there were significant shortfalls in the number of Indigenous Australians with diabetes undergoing screening in the Kimberley region. This may be explained by examinations provided by other services in the Kimberley region, namely visiting optometry services, but also highlights a large proportion of the population not undergoing screening.

Download full-text PDF

Source
http://dx.doi.org/10.1111/ajr.12290DOI Listing

Publication Analysis

Top Keywords

diabetic retinopathy
12
coverage provided
12
retinopathy screening
8
kimberley region
8
region western
8
kimberley diabetic
8
diabetic eye
8
provided program
8
screening
5
coordination diabetic
4

Similar Publications

Background: Glucagon-like peptide-1 (GLP-1) agonists are commonly prescribed for type 2 diabetes mellitus (T2DM). Concerns have emerged regarding their potential link to diabetic retinopathy (DR).

Methods: To evaluate the association between GLP-1 agonists and DR, a disproportionality analysis was conducted using FDA Adverse Event Reporting System (FAERS) data from Q4/2003 to Q2/2024 via OpenVigil 2.

View Article and Find Full Text PDF

The coexistence of type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD) represents a significant global health challenge, contributing to substantial morbidity, mortality, and economic burden. T2DM is the leading cause of CKD, and CKD exacerbates diabetes-related complications, creating a bidirectional relationship driven by oxidative stress, inflammation, and endothelial dysfunction. Diabetic kidney disease (DKD), affecting some individuals with T2DM, accelerates progression to end-stage renal disease (ESRD) and increases cardiovascular mortality.

View Article and Find Full Text PDF

Purpose: Diabetic retinopathy (DR) is a complication of diabetes and a primary cause of visual impairment amongst working-age individuals. DR is a degenerative condition in which hyperglycaemia results in morphological and functional changes in certain retinal cells. Existing treatments mainly address the advanced stages of the disease, which involve vascular defects or neovascularization.

View Article and Find Full Text PDF

Purpose: We report a case of Eales disease in Inuit and reflect on advances in telemedicine and treatment of retinal disease since the first report of Eales' disease in Greenlandic Inuit was published.

Patients And Methods: A 41-year-old Inuit female complaining of blurred vision was referred to our eye department. There had been no sign of diabetic retinopathy during diabetic eye screening and the patient had been treated for tuberculosis in 2010.

View Article and Find Full Text PDF

Metabolic Fingerprint of Dual Body Fluids Deciphers Diabetic Retinopathy.

Small

January 2025

Department of Ophthalmology, National Clinical Research Center for Eye Diseases, Shanghai Gene Therapy Center, Shanghai Key Laboratory of Ocular Fundus Disease, Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200040, P. R. China.

Diabetic retinopathy (DR) is a microvascular complication of diabetes, affecting 34.6% of diabetes patients worldwide. Early detection and timely treatment can effectively improve the prognosis of DR.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!